Joshua Thompson
Psychiatric/Mental Health · Chattanooga, TNNPI 1902275910
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $222,489 of the $261,656 with a category attached, or 85.0%. Neurocrine Biosciences, Inc. accounts for 99.4% of it on its own, with 9 other manufacturers making up the rest. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $924.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$260K
- Johnson & Johnson$435
- Alkermes, Inc.$311
- Otsuka America Pharmaceutical, Inc.$295
- Indivior Inc.$165
- Teva Pharmaceuticals USA, Inc.$149
- plus $322 from 4 others
What the payments were for
- Consulting fees$24,7519%
- Speaking & faculty fees$222,48985%
- Travel & lodging$7,5303%
- Food & beverage$6,8863%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 213 | $259,979 |
| Johnson & Johnson | 17 | $435 |
| Alkermes, Inc. | 16 | $311 |
| Otsuka America Pharmaceutical, Inc. | 10 | $295 |
| Indivior Inc. | 7 | $165 |
| Teva Pharmaceuticals USA, Inc. | 7 | $149 |
| AbbVie | 3 | $133 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $115 |
| Lundbeck LLC | 2 | $55 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$261,656 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $767 |
| Hydroxyzine Hcl | 18 | $444 |
| Duloxetine Hcl | 20 | $432 |
| Haloperidol | 14 | $350 |
| Divalproex Sodium | 17 | $312 |
| Gabapentin | 25 | $296 |
| Mirtazapine | 24 | $287 |
| Pantoprazole Sodium | 33 | $286 |
| Risperidone | 21 | $207 |
| Trazodone Hcl | 30 | $204 |
| Quetiapine Fumarate | 12 | $181 |
| Simvastatin | 48 | $162 |
| Lisinopril | 26 | $147 |
| Olanzapine | 12 | $143 |
| Methocarbamol | 11 | $126 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Chattanooga
- Jason HamrickChattanooga$17K
- Tina FoxChattanooga$14K
- Trena LawsonChattanooga$13K
- Erin LawsonChattanooga$10K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Kristal HurstBlaine$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.